Organization | Jeonbuk National University

Jeonbuk National University Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial

2020

NCT04970940

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Alternative names

Clinical Pharmacology Center, Jeonbuk National University Hospital | Jeonbuk National University Hospita | Jeonbuk National University Hospital | Jeonbuk University Hospital

Active Ingredients

Drugs in Phase 1 Trials (15)

amlodipine (norvasc) (1 trial)

crizotinib (xalkori) (1 trial)

hcp1902 (1 trial)

hgp2001 (1 trial)

hip2001 (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

ilaprazole (noltec) (3 trials)

testosterone (delatestryl) (1 trial)

tocilizumab (actemra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Hypogonadism (Phase 1)

Overview

Highest Phase: Phase 1
# of Trials: 11
# of Trial APIs: 15